Elastic vesicles as topical/transdermal drug delivery systems

International Journal of Cosmetic Science

Volumn 27, Issue 4, 2005, Pages 211-221

  Choi, M J ^a,b   Maibach, H I ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Charmzone Co LTD   (South Korea)

Author keywords

Elastic vesicles; Ethosomes; Stratum corneum; Topical transdermal delivery; Transfersomes

Indexed keywords

LIPOSOME; PHOSPHOLIPID; TRANSFERSOMES;

DIFFUSION; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG PENETRATION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; LIPID VESICLE; NONHUMAN; REVIEW; STRATUM CORNEUM;

EID: 22844434242     PISSN: 01425463     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1467-2494.2005.00264.x     Document Type: Review

References (59)

1. Barry, B.W. Novel mechanisms and devices to enable successful transdermal drug delivery. Eur. J. Pharm. Sci. 14, 101-114 (2001).
2. Schurer, N.Y. and Elias, P.M. The biochemistry and function of stratum corneum lipids. Adv. Lipid Res. 24, 27-56 (1991).
3. Banga, A.K., Bose, S. and Ghost, T.K. Iontophoresis and electroporation: comparison and contrasts. Int. J. Pharm. 179, 1-19 (1999).
4. Regnier, V. and Preat, V. Localization of a FITC-labeled phosphorothioate oligonucleotide in the skin after topical delivery by iontophoresis and electroporation. Pharm. Res. 15, 1596-1602 (1998).
5. Mezei, M. and Gulasekharam, V. Liposomes - a selective drug delivery system for the topical route administration. I. Lotion dosage forms. Life Sci. 26, 1473-1477 (1980).
6. Yoshioka, T., Sternberg, B. and Florence, A.T. Preparation and properties of vesicles (niosomes) of sorbitan monoesters 9Span 20, 40, 60 and 80) and a sorbitan triester (Span 85). Int. J. Pharm. 105, 1-6 (1994).
7. Williams, A.C. and Barry, B.W. Penetration enhancers. Adv. Drug Del Rev. 56, 603-618 (2004).
8. Elias, P.M., Tsai, J., Menon, G.K., Hollern, W.M. and Feingold, K.R. The potential of metabolic interventions to enhance transdermal drug delivery. J. Invest. Dermatol. Sym. Proc. 7, 79-85 (2002).
9. Lasic, D.D. Doxorubicin in sterically stabilized liposomes. Nature 380, 561-562 (1996).
10. Abra, R.M., Bankert, R.B., Chen, F. et al. The next generation of liposome delivery system: recent experience with tumor-targeted, sterically stabilized immunoliposomes and active-loading gradients. J. Liposome Res. 12, 1-3 (2002).
11. Clemons, K.V. and Stevens, D.A. Comparative efficacies of four amphotericin B formulations - Fungizone, amphotech (Amphocil), AmBisome, and Abelcet - against systemic murine aspergillosis. Antimicrob. Agents Chemother. 48, 1047-1050 (2004).
12. Choi, M.J. and Maibach, H.I. Topical vaccination of DNA antigens: topical delivery of DNA antigens. Skin Pharmacol. Appl Skin Physiol. 16, 271-282 (2003).
13. Chang, J.S., Choi, M.J., Cheong, H.S. and Kim, K. Development of Th1-mediated CD8+ effector T cells by vaccination with epitope peptides encapsulated in pH-sensitive liposomes. Vaccine 19, 3608-3614 (2001).
14. Chang, J.S., Choi, M.J., Kim, T.Y., Cho, S.Y. and Cheong, H.S. Immunogenecity of synthetic HIV-1 V3 loop peptides by MPL adjuvanted pH-sensitive liposomes. Vaccine 17, 1540-1548 (1999).
15. Chang, J.S. and Choi, M.J. pH-Sensitive liposomes as adjuvants for peptide antigens. Methods Enzymol. 373, 127-136 (2003).
16. Touitou, E., Junginger, H.E., Weiner, N.D., Nagai, T. and Mezei, M. Liposomes as carriers for topical and transdermal delivery. J. Pharm. Sci. 83, 1189-1203 (1994).
17. Verma, D.D., Verma, S., Blume, G. and Fahr, A. Liposomes increase skin penetration of entrapped and non-entrapped hydrophilic substances into human skin: a skin penetration and confocal laser scanning microscopy study. Eur. J. Pharm. Biopharm. 55, 271-277 (2003).
18. Fang, J.-Y., Hong, C.-T., Chiu, W.-T. and Wang, Y.-Y. Effect of liposomes and niosome on skin permeation of enoxacin. Int. J. Pharm. 219, 61-72 (2001).
19. Mezei, M and Gulasekharam, V. Liposomes - a selective drug delivery system for the topical route administration. Gel dosage form. J. Pharm. Pharmacol. 34, 473-474 (1982).
20. Cevc, G. and Blume, G. Lipid vesicles penetrate into intact skin owing to the transdermal osmotic gradients and hydration force. Biochim. Biophys. Acta 1104, 226-232 (1992).
21. Cevc, G. Transfersomes, liposomes and other lipid suspensions on the skin: permeation enhancement, vesicle penetration, and transdermal drug delivery. Crit. Rev. Ther. Drug Carrier Syst. 13, 257-388 (1996).
22. Van den Bergh, B.A.I. Elastic liquid state vesicles as a tool for topical drug delivery. Thesis, Leiden University, The Netherlands, pp. 49-80 (1999).
23. Honeywell-Nguyen, P.L., Frederik, P.M., Bomans, P.H.H., Junginger, H.E. and Bouwstra, J.A. Transdermal delivery of pergolide from surfactant-based elastic and rigid vesicles: characterization and in vitro transport studies. Pharm. Res. 19, 992-998 (2002).
24. Touitou, E., Dayan, N., Bergelson, L., Godin, B. and Eliaz, M. Ethosomes-novel vesicular carriers: characterization and delivery properties. J. Control Release 65, 403-418 (2000).
25. Cevc, G. and Blume, G. Biological activity and characteristics of triamcinolone-actonide formulated with the self-regulating drug carriers, Transfersomes. Biochim. Biophys. Acta 1614, 156-164 (2003).
26. Cevc, G. Transdermal drug delivery of insulin with ultradeformable carriers. Clin. Pharmacokinet. 42, 461-474 (2003).
27. Cevc, G. and Blume, G. New, highly efficient formulation of diclofenac for the topical, transdermal administration in ultradeformable drug carriers, Transfersomes. Biochim. Biophys. Acta 1514, 191-205 (2001).
28. Hofer, C., Gobel, R., Deering, P., Lehmer, A. and Breul, J. Formulation of interleukin-2 and interferon-alpha containing ultradeformable carriers for potential transdermal application. Anticancer Res. 19, 1505-1507 (1999).
29. Paul, A., Cevc, G. and Bachhawat, B.K. Transdermal immunization with an integral membrane component, gap junction protein, by means of ultradeformable drug carriers, transfer somes. Vaccine 16, 188-195 (1998).
30. Jain, S., Jain, P., Umamaheshwari, R.B. and Jain, N.K. Transfersomes - a novel vesicular carrier for enhanced transdermal delivery: development, characterization, and performance evaluation. Drug Dev. Ind. Pharm. 29, 1013-1026 (2003).
31. Kim, A., Lee, E.H., Choi, S.H. and Kim, C.K. In vitro and in vivo transfection efficiency of a novel ultradeformable cationic liposome. Biomaterials 25, 305-313 (2004).
32. VanKuijk-Meuwissen, M.E.M.J., Junginger, H.E. and Bouwstra, J.A. Interactions between liposomes and human skin in vitro, a confocal laser scanning microscopy study. Biochim. Biophys. Acta 1371, 31-39 (1998).
33. Van den Bergh, B.A., Bouwstra, J.A., Junginger, H.E. and Wertz, P.W. Elasticity of vesicles affects hairless mouse skin structure and permeability. J. Control. Release 62, 367-379 (1999).
34. Schätzlein, A. and Cevc, G. Non-uniform cellular packing of the stratum corneum and permeability barrier function of intact skin: a high-resolution confocal laser scanning microscopy study using highly deformable vesicles (Transfersomes). Br. J. Dermatol. 138, 583-592 (1998).
35. Van den Bergh, B.A.I., Vroom, J., Gerritsen, H., Junginger, H.E. and Bouwstra, J.A. Interactions of elastic and rigid vesicles with human skin in vitro: electron microscopy and two photon excitation microscopy. Biochim. Biophys. Acta 1461, 155-173 (1999).
36. Honeywell-Nguyen, P.L. and Bouwstra, J.A. The in vitro transport of pergolide from surfactant-based elastic vesicles through human skin: a suggested mechanism of action. J. Control. Release 86, 145-156 (2003).
37. Honeywell-Nguyen, P.L., Wouter Groenink, H.W., de Graaff, A.M. and Bouwstra, J.A. The in vivo transport of elastic vesicles into human skin: effects of occlusion, volume and duration of application. J. Control Release 90, 243-255 (2003).
38. Dayan, N. and Touitou, E. Carriers for skin delivery of trihexyphenidyl HCl: ethosomes vs. liposomes. Biomaterials 21, 1879-1885 (2000).
39. Valjakka-Koskela, R., Kirjavainen, M., Mönkkönen, J., Urtti, A. and Kiesvaara, J. Enhancement of percutaneous absorption of naproxen by phospholipids. Int. J. Pharm. 175, 225-230 (1998).
40. Cevc, G., Blume, G., Schätzlein, A., Gebauer, D. and Paul, A. The skin: a pathway for systemic treatment with patches and lipid-based agent carriers. Adv. Drug Del. Rev. 18, 349-378 (1996).
41. Cevc, G., Gebauer, D., Stieber, J., Schätzlein, A. and Blume, G. Ultraflexible vesicles, Transfer somes, have an extremely low pore penetration resistance and transport therapeutic amounts of insulin across the intact mammalian skin. Biochim. Biophys. Acta 1368, 201-215 (1998).
42. El Maghraby, G.M.M., Williams, A.C. and Barry, B.W. Oestradiol skin delivery from deformable liposomes: refinement of surfactant concentration. Int. J. Pharm. 196, 63-74 (2000).
43. El Maghraby, G.M.M., Williams, A.C. and Barry, B.W. Skin delivery of oestradiol from lipid vesicles: importance of liposome structure. Int. J. Pharm. 204, 159-169 (2000).
44. Trotta, M., Peira, E., Debernardi, F. and Gallarate, M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int. J. Pharm. 241, 319-327 (2002).
45. Guo, J., Ping, Q., Sun, G. and Jiao, C. Lecithin vesicular carriers for transdermal delivery of cyclosporin A. Int. J. Pharm. 194, 201-207 (2000).
46. El Maghraby, G.M.M., Williams, A.C. and Barry, B.W. Skin delivery of 5-fluorouracil from ultrade-formable and standard liposomes in-vitro. J. Pharm. Pharmacol. 53, 1069-1077 (2001).
47. Cevc, G. and Blume, G. and Schätzlein, A. Transfersomes-mediated transdermal delivery improves the regiospecificity and biological activity of corticosteroids in vivo. J. Control. Release 45, 211-226 (1997).
48. Trotta, M., Peira, E., Carlotti, M.E. and Gallarate, M. Deformable liposomes for dermal administration of methotrexate. Int. J. Pharm. 270, 119-125 (2004).
49. Honeywell-Nguyen, P.L., van den Bussche, M.H., Junginger, H.E. and Bouwstra, J.A. The effect of surfactant-based elastic and rigid vesicles on the penetration of lidocaine across human skin. STP Pharma 12, 257-262 (2002).
50. Bouwstra, J.A., DeGraaff, A., Groenik, W. and Honeywell, L. Elastic vesicles: interaction with human skin and drug transport. Cell. Mol. Biol. Lett. 7, 222-223 (2002).
51. Honeywell-Nguyen, P.L., Arenja, S. and Bouwstra, J.A. Skin penetration and mechanisms of action in the delivery of the D2-agonist rotigotine from surfactant-based elastic vesicle formulation. Pharm. Res. 20, 1619-1625 (2003).
52. Touitou, E. Compositions for applying active substances to or through the skin. US patent 5,540,934 (1996).
53. Fang, J.-Y., Yu, S.-Y., Wu, P.-C., Huang, Y.-B. and Tasi, Y.-H. In vitro skin permeation of oestradiol from various proniosome formulations. Int. J. Pharm. 215, 91-99 (2001).
54. Vora, B., Khopade, A.J. and Jain, N.K. Proniosome based transdermal delivery of levonorgestrel for effective contraception. J. Control, Release 54, 149-165 (1998).
55. Touitou, E., Godin, B. and Weiss, C. Enhanced delivery of drugs into and across the skin by ethosomal carriers. Drug Dev. Res. 50, 406-412 (2000).
56. Godin, B. and Touitou, E. Mechanism of bacitracin permeation enhancement through the skin and cellular membranes from an ethosomal carrier. J. Control. Release 94, 365-379 (2004).
57. Touitou, E., Godin, B., Dayan, N. et al. Intracellular delivery mediated by an ethosomal carrier. Biomaterials 22, 3053-3059 (2001).
58. Horwitz, E., Pisanty, S., Czerninski, R. et al. A clinical evaluation of a novel liposomal carrier for acyclovir in the topical treatment of recurrent herpes labialis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod. 87, 700-705 (1999).
59. Lodzki, M., Godin, B., Rakou, L. et al. Cannabidiol-transdermal delivery and anti-inflammatory effect in murine model. J. Control. Release 93, 377-387 (2003).